[go: up one dir, main page]

BR9609871A - Vacina de urease recombinante multimérica - Google Patents

Vacina de urease recombinante multimérica

Info

Publication number
BR9609871A
BR9609871A BR9609871-6A BR9609871A BR9609871A BR 9609871 A BR9609871 A BR 9609871A BR 9609871 A BR9609871 A BR 9609871A BR 9609871 A BR9609871 A BR 9609871A
Authority
BR
Brazil
Prior art keywords
compositions
multimeric
helicobacter
processes
recombinant urease
Prior art date
Application number
BR9609871-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Cynthia K Lee
Thomas P Monath
Samuel K Ackerman
William D Thomas Jr.
Gopalan Soman
Harold Kleanthous
Richard A Weltzin
Jacques Pappo
Thomas Ermak
Farshad Guirakhoo
Hitesh Bhagat
Ilene Sussman
Original Assignee
Ora Vax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ora Vax Inc filed Critical Ora Vax Inc
Publication of BR9609871A publication Critical patent/BR9609871A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9609871-6A 1995-04-28 1996-04-25 Vacina de urease recombinante multimérica BR9609871A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43104195A 1995-04-28 1995-04-28
US56812295A 1995-12-06 1995-12-06
PCT/US1996/005800 WO1996033732A1 (fr) 1995-04-28 1996-04-25 Vaccin d'urease recombinante et multimere

Publications (1)

Publication Number Publication Date
BR9609871A true BR9609871A (pt) 2000-03-28

Family

ID=27028868

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9609871-6A BR9609871A (pt) 1995-04-28 1996-04-25 Vacina de urease recombinante multimérica

Country Status (15)

Country Link
EP (1) EP0831892B1 (fr)
JP (1) JPH11504633A (fr)
KR (1) KR19990008155A (fr)
AT (1) ATE433325T1 (fr)
AU (1) AU723063B2 (fr)
BR (1) BR9609871A (fr)
CA (1) CA2219201A1 (fr)
CZ (1) CZ342697A3 (fr)
DE (1) DE69637947D1 (fr)
HU (1) HUP9801266A3 (fr)
MX (1) MX9708319A (fr)
NO (1) NO974969L (fr)
NZ (1) NZ307017A (fr)
PL (1) PL185013B1 (fr)
WO (1) WO1996033732A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2637612B1 (fr) * 1988-10-06 1993-09-10 Pasteur Institut Sequences de nucleotides codant pour une proteine a activite ureasique
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
DE19521314A1 (de) * 1995-06-12 1996-12-19 Max Planck Gesellschaft Adhärenzgen aus Helicobacter pylori und davon codiertes Polypeptid
EP0835928A1 (fr) * 1996-10-11 1998-04-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin Vaccin vivant d'hélicobacter pylori
AU735391B2 (en) * 1996-11-14 2001-07-05 Human Genome Sciences, Inc. Helicobacter polypeptides and corresponding polynucleotide molecules
US6248551B1 (en) 1997-03-28 2001-06-19 Institut Pasteur Helicobacter aliphatic amidase AmiE polypeptides, and DNA sequences encoding those polypeptides
US6599509B2 (en) * 1997-09-02 2003-07-29 Massachusetts Institute Of Technology Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease
GB9718616D0 (en) * 1997-09-02 1997-11-05 Queen Mary & Westfield College Oral vaccine
US5985631A (en) * 1997-09-12 1999-11-16 Oravax-Merieux Co. Method for preventing the activation of inactive, recombinant Helicobacter pylori apourease
CA2335487A1 (fr) 1998-06-19 1999-12-23 Merieux Oravax Enterotoxine thermolabile et toxine cholerique dans des procedes d'immunisation parenterale contre les infections a helicobacter
US6190667B1 (en) 1998-06-30 2001-02-20 Institut Pasteur Methods of inhibiting Helicobacter pylori
AU8464398A (en) * 1998-07-16 2000-02-07 Cheil Jedang Corporation Urease based vaccine against (helicobacter) infection
WO2003059380A2 (fr) * 2002-01-15 2003-07-24 Bio Life Science Forschungs Und Entwicklungsges M.B.H. Vaccination orale
EP1327450B1 (fr) * 2002-01-15 2007-08-15 Bio Life Science Forschungs- und Entwicklungsges.m.b.H. Vaccination orale par des mimotopes d'antigene tumoraux dénudés
WO2005113603A1 (fr) * 2004-05-18 2005-12-01 Universite De Lausanne Eradication d'une infection a helicobacter par activation de mastocytes dans l'estomac
CN100460013C (zh) * 2006-09-05 2009-02-11 重庆康卫生物科技有限公司 口服重组幽门螺杆菌疫苗及其制备方法
CN100535119C (zh) * 2006-11-07 2009-09-02 上海交通大学医学院附属第九人民医院 一种制备唾液链球菌尿素酶基因的方法
CN101955545B (zh) * 2010-09-07 2012-07-04 四川万可泰生物技术有限责任公司 一种多靶点重组基因及其蛋白在防治幽门螺旋杆菌感染中的应用
CN113433087A (zh) * 2021-06-22 2021-09-24 中南大学 一种尿素浓度快速检测方法及检测传感器和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
US5972336A (en) * 1992-11-03 1999-10-26 Oravax Merieux Co. Urease-based vaccine against helicobacter infection
WO1995014093A1 (fr) * 1993-05-19 1995-05-26 Institut Pasteur Compositions immunogenes dirigees contre les infections par helicobacter, polypeptides utilisables dans ces compositions, et sequences d'acides nucleiques codant ces polypeptides
FR2732605B1 (fr) * 1995-04-07 1997-05-16 Pasteur Merieux Serums Vacc Composition destinee a l'induction d'une reponse immunitaire mucosale

Also Published As

Publication number Publication date
WO1996033732A1 (fr) 1996-10-31
PL323048A1 (en) 1998-03-02
HUP9801266A2 (hu) 1998-08-28
AU5576496A (en) 1996-11-18
HUP9801266A3 (en) 1999-07-28
DE69637947D1 (de) 2009-07-23
CA2219201A1 (fr) 1996-10-31
EP0831892A4 (fr) 2002-06-26
JPH11504633A (ja) 1999-04-27
MX9708319A (es) 1998-08-30
PL185013B1 (pl) 2003-01-31
EP0831892B1 (fr) 2009-06-10
ATE433325T1 (de) 2009-06-15
AU723063B2 (en) 2000-08-17
NO974969D0 (no) 1997-10-27
KR19990008155A (ko) 1999-01-25
NZ307017A (en) 1999-07-29
CZ342697A3 (cs) 1998-06-17
NO974969L (no) 1997-12-23
EP0831892A1 (fr) 1998-04-01

Similar Documents

Publication Publication Date Title
BR9609871A (pt) Vacina de urease recombinante multimérica
PL317105A1 (en) Compositions containing dna and p53 damaging agents
BG101118A (en) Therapeutical compounds
DE69818707D1 (de) Chitosan und influenza-antigen(e) enthaltende impfstoff-zubereitungen zur verabreichung durch eine mukosa
PL350658A1 (en) Medical preparations for the treatment of alpha−galactosidase a deficiency
BR9206632A (pt) Sistema de penetração na pele melhorado para melhorada liberação tópica de drogas
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
MX9406552A (es) Metodo, composiciones y dispositivos para la admi nistracion de polinucleotidos desnudos que codifi can peptidos biologicamente activos.
EP0786458A3 (fr) Dérivés et analogues d'acide 2-déoxy-2,3-didéhydro-N-acétyle neuraminique et leur utilisation comme agents antiviraux
CA2293470A1 (fr) Derives de benzimidazole
ES2159630T3 (es) Sistema de administracion por via oral de proteinas g-csf quimicamente modificadas.
EP0979080A4 (fr) Procede de modulation d'une reaction immunitaire chez un mammifere infecte par administration transmuqueuse d'un agent de modulation
ATE344664T1 (de) Verbesserte methode zur eradikation von helicobacter pylori
IL90499A0 (en) Therapeutic uses of 2',5'-oligoadenylates
DK0640098T3 (da) S-gen fra hundecoronavirus og anvendelser deraf
DE69709891D1 (de) Chitosan enthaltende zusammensetzung
ES2128353T3 (es) Composicion topica que contiene penciclovir.
ATE223700T1 (de) Ramoplaninhaltige neue injizierbare arzneizubereitungen
IT1255678B (it) Composizioni farmaceutiche per la somministrazione di paratormone, suoi frammenti biologicamente attivi o peptidi correlati per via rettale.
IT1258818B (it) Composizioni farmaceutiche orali a base di n5-metiltetraidrofolato di calcio
BR9810930A (pt) Composições farmacêuticas de arglabina e derivados de arglabina

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
FA14 Dismissal: dismissal - article 34 of industrial property law
B11T Dismissal of application maintained [chapter 11.20 patent gazette]